40. Greenbaum LA, Benador N, Goldstein SL et al. Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis. Correspondence and offprint requests to: Shiren Sun; E-mail: sunshiren@medmail.com.cn † These authors contributed equally to this work.
Background. Our previous studies demonstrated that URG11 is involved in hypoxia-induced tubular epithelial-mesenchymal transition and the development of kidney fibrosis in cellular and animal models. The objective of this study was to determine the expression levels of URG11 in kidneys with IgA nephropathy (IgAN), and the association of URG11 with various clinical parameters. Methods. We analysed the degree of expression and localization of URG11 in biopsies from kidneys with IgAN, and correlated their immunostaining levels with various clinical and histological parameters. We also analysed the correlation between the expression of URG11 and Twist in the renal interstitium with renal survival.
Results. URG11 was strongly expressed in the cytoplasm of tubular epithelial cells obtained from kidneys of patients with IgAN. However, there was little positive staining for URG11 in the renal tubules of normal kidneys (P = 0.024). URG11 protein levels in the tubulointerstitium were inversely correlated with estimated glomerular filtration rates (eGFRs) (r = −0.305, P = 0.038) and the percentage of tubulointerstitial fibrosis (r = 0.350, P = 0.023). Moreover, a high level of URG11 correlated with the activation of Twist expression and E-cadherin repression in patients with IgAN (P = 0.000 and 0.041, respectively). Multivariate analyses indicated that a combination of high URG11 and Twist expression was an independent prognostic factor [relative ratio, RR 4.738 (95% CI: 1.040, 21.591), P = 0.044] of IgAN. Conclusions. Our findings suggest that URG11 staining in renal biopsy specimens might be a novel histological marker for progression in IgAN patients.
I N T RO D U C T I O N
Upregulated gene 11 (URG11) was originally identified as one of the genes upregulated in HB×Ag-positive HepG2 cells compared with HB×Ag-negative cells via PCR-select cDNA subtraction [1] . It was later revealed that an overexpression of URG11 is critical in HB×-related hepatocellular carcinoma (HCC) through the transactivation of β-catenin [2] . Expression of URG11 induces an overexpression and nuclear accumulation of β-catenin in HCC cells, which promotes HCC cell growth [2] . Conversely, adenovirus-mediated transfer of siRNA against URG11 represses HCC cellular growth in vivo and reduces tumour formation in vitro [3] . Recently, our laboratory demonstrated that URG11 plays a key role in tumour metastasis in a gastric cancer model. The expression of both URG11 and β-catenin was positively correlated in metastatic gastric cancer tissues. Further studies demonstrated that URG11 upregulated the transcription of β-catenin via the β-catenin promoter in gastric cancer cells, increased the expression of target genes and thereby promotes gastric cancer cell invasion and metastasis [4, 5] . More recently, a study by Yuan et al. showed that URG11 promotes the expression of miR-148a, which suppresses the translation of PTEN, and activates PI3K/Akt and β-catenin [6] .
In addition to its role in tumourigenesis and tumour metastasis, studies from our laboratory indicate that URG11 has a critical functional role in tubular epithelial-mesenchymal transition (EMT) and kidney fibrosis [7] . Our work demonstrated that URG11 mediated hypoxia-induced tubular epithelial cell EMT and renal fibrosis. Moreover, URG11 has been shown to be over-expressed in a rat model of chronic hypoxia (5/6 nephrectomy) [7] . However, the expression and clinical significance of URG11 in patients with chronic hypoxic kidney disease are unclear. In the present study, we determined the expression of URG11 in kidneys with IgA nephropathy (IgAN), and assessed whether the degree of URG11 expression in the renal interstitium is correlated with renal survival.
M E T H O D S

Renal biopsies
Renal biopsy samples from patients diagnosed with IgAN between February 2007 and July 2008 at the Xijing Hospital were reviewed. The entry criteria were a biopsy-proven IgAN (defined by standard morphological and immunohistochemical criteria), patients with liver diseases, Henoch-Schönlein purpura nephritis, diabetic nephropathy and lupus nephritis were excluded from the study. Treatment options for IgAN patients include general measures, corticosteroid and immunosuppressive therapy, anticoagulant and anti-platelet therapy. IgAN patients with various clinical presentations and pathological features receive different therapy options, cases with at least 10 glomeruli in the biopsy sample were selected for further study. Renal biopsy samples were processed using standard techniques for immunochemistry, and a clinical diagnosis was made based on the immunostaining findings. The corresponding histopathological and clinical information was collected via a review of the charts. The percentage of glomerulosclerosis and tubulointerstitial fibrosis was obtained from the standard pathology report [8] .
This study was approved by the Hospital's Protection of Human Subjects Committee and an informed consent was obtained from all patients. Renal survival was defined as the duration of time between the date of the renal biopsy until the endpoint, which was a 100% increase in serum creatinine from baseline or the development of end-stage renal disease (ESRD). To assess the correlations between URG11 and Twist expression levels with renal function, patients were divided into two groups based on the extent of changes in renal function: (i) a ≥100% increase in serum creatinine from baseline or the development of ESRD and (ii) a <100% increase in serum creatinine from baseline. Hypertension was defined as a systolic blood pressure >140 mmHg and a diastolic pressure >90 mmHg. Urine and blood samples collected at the time of renal biopsy (baseline) were analysed for serum creatinine, and 24 h total protein excretion. Serum creatinine was measured and recorded every 3-6 months and at the end of each follow-up year.
Immunohistochemistry
For immunohistochemistry, 3-to 5-μm thick sections were cut. Slides were de-waxed, rehydrated and incubated with 3% hydrogen peroxide for 30 min, and blocked in 10% normal goat serum for 1 h. The expression levels of URG11, Twist and E-cadherin were evaluated with immunohistochemical staining techniques using the avidin-biotin peroxidase complex method (LSAB2 kit, Dako, Glostrup, Denmark). The slides were then incubated with primary antibodies, including anti-human URG11 monoclonal antibody (diluted 1 : 1000; prepared and characterized by our laboratory [4] ), rabbit anti-Twist (diluted 1:100, Santa Cruz) or rabbit anti-E-cadherin (diluted 1:100, Santa Cruz) at 4°C overnight. Negative control slides using normal mouse immunoglobulin G (Vector Labs, Burlingame, CA) as the primary antibody were included in all assays. The sections were incubated with a biotinylated goat anti-rabbit or antimouse IgG as the secondary antibody, and the antibody reactions were visualized using diaminobenzidine (DAKO, Tokyo, Japan). Non-immune goat IgG or rabbit IgG were used as negative controls. The slides were counterstained with haematoxylin, dehydrated and mounted.
Image analysis
Slides were examined with an OLYMPUS (ShangHai) CX41-32C02 microscope, and pictures were taken with an OLYMPUS DSE330 camera. Immunostaining was evaluated in a blinded manner, as previously described [9] . The immunostaining score was determined by counting the URG11-/ Twist-positive tubular epithelial cells under a microscope at ×200 magnification on 10 random fields. A relative scale of 0-3 was used to grade the amount of URG11 and Twist immunostaining, where 0 indicates <5% staining, 1+ indicates 5-25% staining, 2+ indicates 25-50% immunostaining and 3+ indicate >50% immunostaining. A negative/positive relative scale was used to grade the amount of E-cadherin immunostaining, where a negative (−) indicates a loss or reduced membrane expression of E-cadherin, and a positive (+) indicates a preserved membrane expression of E-cadherin in tubular epithelial cells.
Statistical analysis
All data are expressed as mean ± standard deviation. The chi-squared test was used for comparisons of dichotomous variables. Comparisons of three or more variables were performed by using a one-way ANOVA followed by Fisher's protected least significant difference test. Linear regression analyses were conducted to determine the correlations between URG11 expression levels and various clinical and histological parameters. Renal survival was estimated via KaplanMeier plots. To assess the prognostic impact of URG11 and Twist expression levels on renal survival, the univariate and multivariate effects of various covariates on renal survival were evaluated via the log-rank test and Cox proportional hazards model, respectively. The level of significance was set at P < 0.05. All statistical analyses were performed with SPSS 12.0 (SPSS Inc., Chicago, Ill.).
R E S U LT S
Patients' characteristics and renal histology A total of 86 biopsy samples from subjects with IgAN were examined. The demographic and clinical characteristics of the research participants at the time of the renal biopsy are summarized in Table 1 . The patients in our study ranged from 14 to 74 years of age (mean 33.59 ± 13.72 years old). There was an overrepresentation of males (54.65%), and all cases presented with proteinuria [i.e. baseline of 0.97 90.50-1.65] g/24 h).
Expression of URG11 in renal tissue samples from patients with IgAN
To determine the relationship between URG11 expression and clinicopathological features, we assessed the expression levels of URG11 in IgAN via immunohistochemistry. Tissue sections were analysed for the subcellular localization of staining and scored based on the percentage of URG11-expressing cells. As shown in Figure 1 , URG11 was predominantly located in the cytoplasm of renal tubular epithelial cells from IgAN patients. Despite the little positive staining for URG11 in the renal tubules of normal kidneys (i.e. URG11 score of ≤1 and absence in glomeruli; Figure 1 ), prominent URG11 staining (>25% of all cells were positive) was found in 49 out of 86 patients (URG11 score of ≥2+, P = 0.022, when grouped by score of ≥2+ or <2+; Fisher's exact test; Table 2 ). These results indicate that URG11 is overexpressed in IgAN, and that the sensitivity and specificity of URG11 for IgAN are 57.0 and 87.5%, respectively.
Correlation of URG11 with clinical or histological parameters
To clarify the potential role or involvement of URG11 in the progression of IgAN, we examined the relationships between various clinical and histological parameters with staining for URG11. Among the clinical parameters tested (Table 3) , the expression levels of URG11 protein in the tubulointerstitium was inversely correlated with eGFR (r = −0.305, P = 0.038). There were no correlations between URG11 expression levels and other clinicopathological factors, including the amount of proteinuria, hypertension, serum creatinine, gender and age.
We, then, studied whether there were correlations between URG11 protein expression levels and histological parameters. The immunostaning score of URG11 in the tubulointerstitium was correlation with the percent of tubulointerstitial fibrosis (r = 0.350, P = 0.023, Table 3 ). Linear regression analyses showed that the percentage of URG11-positive cells in the tubulointerstitium was closely correlated with the percentage of tubulointerstitial fibrosis (r = 0.580, P = 0.000, Figure 2 ). These results indicate that the expression of URG11 correlates with the degree of tubulointerstitial fibrosis in IgAN patients.
Overexpression of URG11 is correlated with Twist expression and inversely correlated with E-cadherin expression in IgAN patients Twist is a well-established mesenchymal marker for the EMT process in renal tubular cells [10, 11] . Herein, we investigated the relationship between Twist and URG11 in renal tissues of patients with IgAN. Tissues from 86 IgAN patients were stained for URG11 and Twist. The representative IHC results are shown in Figure 3 . Twist was predominantly located in the nuclei of renal tubular epithelial cells from IgAN patients. Positive Twist was observed in the nuclei in 61.6% (53/86) of IgAN kidney tissues, which is consistent with the finding of previous work (11) . Furthermore, the IHC grading of URG11 was closely associated with that of Twist (P = 0.000; Figure 3 , Table 4 ). An inverse correlation between URG11 and E-cadherin expression has been recently reported in a mouse model of renal fibrosis by our laboratory [7] . Herein, we investigated the relationship between URG11 and E-cadherin suppression in renal fibrosis. As shown in Figure 3 , strong membrane labelling was the typical distribution pattern of E-cadherin in normal tubular epithelial cells, whereas reduced and even 
O R I G I N A L A R T I C L E
U R G 1 1 a n d t w i s t i n I g A N diminished membrane labelling of E-cadherin was observed in 55.8% (48 of 86) of IgAN renal tissues. An absence of or reduced expression of E-cadherin was observed in 67.3% (33 of 49) of URG11-positive biopsies, but only in 40.5% (15 of 37) of URG11-positive biopsies. The expression of E-cadherin was inversely associated with URG11 expression levels in all kidney tissues from IgAN patients, and a lower expression level of URG11 in tubular epithelial cells was correlated with a reduction in the downregulation of E-cadherin (P = 0.041; Figure 3 , Table 5 ).
Both URG11 and Twist are correlated with the worst outcome in IgAN patients
To determine whether staining for URG11 correlated with the long-term prognosis of chronic kidney disease (CKD) patients, we prospectively analysed 86 IgAN patients. The follow-up period ranged from 6 to 60 months (average 49.7 months), during which a total of 26 patients (30.2%) reached the endpoint (i.e. a doubling in baseline serum creatinine). Eleven patients (9.43%) progressed to ESRD. The significance of each factor that affects the renal survival rate is presented in Table 6 . Among the clinical parameters, urinary protein excretion (≥1.0 g/day), hypertension, high serum creatinine (≥1.0 mg/dL) and low eGFR (<60 mL/min) were significant risk factors for renal function deterioration, where the gender and age were not. Using multivariate analyses (Table 7) , urinary protein excretion, hypertension and eGFR were found to be significantly associated with renal function deterioration.
Of the histological parameters tested, univariate analyses showed that a high incidence of tubulointerstitial fibrosis (≥30% of the total specimen area), tubulointerstitial fibrosis (≥20% of the total specimen area), a URG11 immunostaining score of ≥2 and a Twist immunostaining score of ≥2 were all significant risk factors for renal function deterioration (Table 6 ). Multivariate analyses (Table 7) revealed that a higher level of Twist per se, but not URG11, was associated with a diminished renal survival. Higher levels of both URG11 and Twist were associated with the worst survival rate compared with other groups of patients. Kaplan-Meier curves revealed that an increased expression of both URG11 and Twist [relative ratio, RR, 4.738 (95% CI: 1.040, 21.591), P = 0.044] was associated with a diminished renal survival (Figure 4) . In summary, our findings demonstrate that higher levels of URG11 and Twist are associated with the worse outcome in IgAN patients.
D I S C U S S I O N
The present study characterized the expression levels of URG11 in normal kidneys, and in the renal tissues from a cohort of patients with chronic hypoxia renal disease. IgAN was chosen as a model of chronic hypoxia kidney disease, since chronic hypoxia is recognized to be important in the determination of the long-term renal survival in these patients [12] [13] [14] .
Previous studies have shown that URG11 was involved in hypoxia-induced renal tubular EMT, and that an overexpression of URG11 was observed in a mouse model of tubulointerstitial fibrosis [7] . In the present study, our experimental data demonstrated that 57.0% of renal tissues from IgAN patients demonstrated high URG11 expression levels, whereas there was little URG11 expression in the tubular epithelial cells of normal renal tissues. We also studied the relationships between URG11 expression levels and renal histological parameters. We confirmed that there was a close correlation between URG11 immunostaining in the tubulointerstitium and areas of fibrosis in renal biopsies. These results suggest that URG11 may play a role in the development of kidney tubulointerstitial fibrosis in humans.
Twist, a basic helix-loop-helix transcription factor, is a well-established mesenchymal marker in tumour and renal tubular epithelial cells [10, 11, [15] [16] [17] . Our previous work demonstrated that Twist mediated hypoxia-induced tubular epithelial cell EMT, and confirmed that Twist can be used as a novel prognostic marker for renal survival in patients with CKD [10] . We also detected the expression levels of Twist in consecutive samples of renal tissues. Twist was expressed in 65.1% of tubular epithelial cells of IgAN patients, which was in agreement with our previous work. Moreover, the expression levels of Twist were significantly associated with URG11 (P = 0.000), suggesting that URG11 may be involved in EMT, as observed in HK2 cells, and that URG11 may play a pivotal role in renal fibrosis.
Our previous study demonstrated that URG11 could induce E-cadherin repression in tubular epithelial cells. E-cadherin is an epithelial cell-cell adhesion protein, which plays a key role in the formation and maintenance of epithelia in the embryonic stage, as well as in the homeostasis and maintenance of the epithelial tissue architecture in adult tissues [18] [19] [20] . Loss of E-cadherin is the first step of tubular epithelial cell EMT [36] , which is an important mechanism underlying the development of tubulointerstitial fibrosis [21] [22] [23] . Herein, we evaluated the expression of E-cadherin in renal biopsies of IgAN patients. It was found that an absence or reduction of E-cadherin correlated with high expression levels of URG11. Therefore, we speculate that high URG11 expression may induce EMT via a dysregulation of the E-cadherin expression pattern in IgAN.
In the present study, we also confirmed that proteinuria, hypertension, and eGFR are univariate risk factors of renal survival. Moreover, proteinuria (>1 g/24 h), hypertension and eGFR (<60 mL/min) were multivariate predictors of renal function deterioration. These findings corroborate previous reports that demonstrated that proteinuria, hypertension, kidney disease etiology and eGFR are risk factors for the progression to ESRD in CKD patients [24, 25] . Histological findings were also previously reported to be good predictors of outcome for IgAN patients, including glomerular lesions and interstitial fibrosis. In the present study, we confirmed that a high incidence of tubulointerstitial fibrosis (≥30% of total specimen area) was a univariate predictor of renal function deterioration. Our experimental data demonstrated that URG11 and Twist activation in the tubulointerstitium were univariate predictors of renal function deterioration. An absence or reduction of E-cadherin was another univariate predictor of renal function deterioration in our study. However, URG11 overexpression and E-cadherin suppression were not found to be significant risk factors via multivariate analyses. Interestingly, our results show that strong staining for URG11/Twist in epithelial cells is a multivariate predictor of renal function deterioration. In fact, strong staining for both URG11 and Twist (≥2+) was indicative of a 4.738-fold increase in the risk of progression to renal function deterioration. Figure 4 demonstrates that an activation of URG11/ Twist was associated with decreased renal survival. URG11 could activate β-catenin and β-catenin/TCF signalling in HK2 cells [7] . Given that Twist was identified as an important β-catenin/TCF signalling target gene [26] , we hypothesized that the URG11-β-catenin-Twist signal pathway may play a key role in renal tubular epithelial cells EMT and renal fibrosis. Our present study demonstrated that the activation of URG11/ Twist was associated with decreased renal survival. However, whether URG11 activates Twist expression via β-catenin/TCF signalling requires further investigation.
This study has several limitations. First, this is a retrospective study with a small study population. Second, the followup time is relatively short to observe the renal outcome. Finally, IgAN patients with various clinical presentations and pathological features receive different therapy options, and outcome of the therapy might affect renal outcome. Despite this, we for the first time provided a clue for the role of combination of URG11 and Twist in predicting IgAN patients' outcome.
In conclusion, we found that URG11 is upregulated in renal tissues from IgAN patients. A tubulointerstitial abundance of URG11 is associated with Twist activation, Ecadherin suppression and poor renal survival. Our findings indicate that URG11/Twist activation may be crucial for tubulointerstitial fibrosis. These results may aid in understanding the pathogenesis of IgAN, as well as the in the development of novel candidate molecular markers and therapeutic targets [27, 28] . 
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